Neurology News

Former professional football players’ cognitive performance decades after retirement was associated with retrospectively reported concussion symptoms but not concussion diagnosis or length of playing career, according to new research.

The FDA has cleared Abbott’s laboratory blood test for concussion, making it the first commercially available test of its kind, according to a company press release.

Biopharmaceutical company Aptinyx reported its drug for cognitive impairment was not efficacious in a phase 2 clinical trial investigating its use in patients with Parkinson’s disease and Lewy body dementia, according to a press release.

Perceived stress was associated with both prevalent and incident cognitive function impairment in Black and white older adults, underlining the need for stress assessments among high-risk adults in primary care, according to researchers.

The brains of F16 fighter pilots exhibited distinct differences in motor, vestibular and multisensory processing compared with those of non-pilots and may provide valuable insight into the effects of space travel, according to research.

Regions of the brain associated with executive function in adults are similarly recruited in children as young as 4 years, according to findings published in the Journal of Neuroscience.

Vistagen announced that the U.S. Patent and Trademark Office granted a patent for the company’s investigational pherine PH80 nasal spray for the treatment of migraine.

The FDA has granted 510(k) clearance to Neuro20 Technologies for its Neuro20 Pro System, a wearable whole-body electrical muscle stimulator suit, software and operating system for neuromuscular injuries and disease.

SAN DIEGO — Advances in the ability to measure chronic, active inflammation in MS using MRI and positron emission tomography may improve disease diagnosis and prognosis, according to research presented at ACTRIMS 2023.

SAN DIEGO — Physicians should emphasize the importance of diet and lifestyle change in patients with MS and consider home environment, cultural challenges and other factors when making recommendations, a presenter noted at ACTRIMS 2023.